Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to $55.6 million.

  • Coherus Oncology's Non-Current Assets fell 5913.69% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $282.7 million, marking a year-over-year decrease of 4793.84%. This contributed to the annual value of $107.0 million for FY2024, which is 3053.98% down from last year.
  • Coherus Oncology's Non-Current Assets amounted to $55.6 million in Q3 2025, which was down 5913.69% from $59.3 million recorded in Q2 2025.
  • Coherus Oncology's 5-year Non-Current Assets high stood at $154.0 million for Q4 2023, and its period low was $55.6 million during Q3 2025.
  • Over the past 5 years, Coherus Oncology's median Non-Current Assets value was $86.5 million (recorded in 2023), while the average stood at $95.8 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 5730.4% in 2024, then plummeted by 5913.69% in 2025.
  • Coherus Oncology's Non-Current Assets (Quarter) stood at $77.0 million in 2021, then rose by 29.35% to $99.6 million in 2022, then soared by 54.57% to $154.0 million in 2023, then tumbled by 30.54% to $107.0 million in 2024, then tumbled by 48.05% to $55.6 million in 2025.
  • Its Non-Current Assets stands at $55.6 million for Q3 2025, versus $59.3 million for Q2 2025 and $60.9 million for Q1 2025.